RETICULOSE Use Reported on "48 Hours"
Fri Jan 13 17:51:17 EST 1995
RETICULOSE Reported on CBS ³48 Hours² Being Used
Experimentally in Treatment of Patients
Advanced Viral Research Corp., (³The Company²) (ADVR-OTC) announced today
that the January 12, 1995 edition of the CBS Television program ³48 Hours²
concerning alternative medicine, had reported the experimental use of
Reticulose is an experimental peptide product owned and developed by
Advanced Viral Research Corp. It is not currently approved by the FDA.
It is being researched for clinical efficacy in several foreign countries,
utilizing controlled scientific studies.
C.U.R.E Pharmaceuticals only has limited distribution contracts for
registration and distribution in certain foreign countries. They are not the
discover or redeveloper of Reticulose, or the spokesperson for Reticulose.
Advanced Viral Research Corp.
E-Mail: avr at ico.com
More information about the Bioforum